1 To whom correspondence should be addressed in the cDNA occurring at a common site (Tischer et al., 1991) . The four transcripts encoded a 26 amino acid hydrophobic Models of the platelet-derived growth factor (PDGF)-like signal sequence and had identical mature amino termini. The domains of vascular endothelial growth factor (VEGF) and transcript encoding the 46 kDa form generates a 165 amino placenta growth factor (PIGF) were built based on their acid peptide following signal cleavage; this peptide is known homology to PDGF. These domains contain most of the as VEGF 165 . The other transcripts encode VEGF 121 , which has determinants for receptor binding. The sequences of these proteins exhibit limited but significant homology to that of a 44 amino acid deletion between positions 116 and 159 of platelet-derived growth factor (PDGF), a member of the VEGF 165 , VEGF 189 , which has 24 amino acids inserted at cystine knot growth factor family. The eight cysteine position 116, and VEGF 206 , which has 41 amino acids inserted residues that are involved in intra-and interchain disulat position 116 (Tischer et al., 1991) . phide bonds are conserved. Two high affinity receptors for Two tyrosine kinases, fms-like tyrosine kinase (flt-1) and VEGF have been identified, only one of which binds PIGF.
the kinase insert domain-containing receptor (KDR) have been The models presented here are consistent with results that identified as the high affinity receptors for VEGF (de Vries show that VEGF receptor binding is mediated by charged et al., 1992; Terman et al., 1992) . The murine homologue of residues in the loops. A comparison of the models suggests KDR is flk-1, whose sequence is 85% identical with that of that the difference in receptor-binding specificity between KDR. The flt-1 and KDR genes encode tyrosine kinase VEGF and PIGF may be due to differences in the distribureceptors consisting of an extracellular domain containing tion of positively charged residues and the exposure of seven immunoglobulin domains, a transmembrane domain hydrophobic residues in the loops.
and a split tyrosine kinase intracellular domain (Shibuya Keywords: cystine knot growth factors/homology modelling / et al., 1990) . PIGF/receptor-binding determinants/VEGF
The longer forms of VEGF bind heparin through a site that appears to be distinct from the receptor-binding domain (Vaisman et al., 1990) . The heparin binding site is located in the basic C-terminal region of the longer forms of VEGF since Introduction VEGF 165 can be cleaved by plasmin to yield VEGF 110 , which In the early 1970s, it was hypothesized that tumour growth lacks residues 111-165 and has no affinity for heparin (Park depends on angiogenesis and that the inhibition of angioet al., 1993) . Since the sequence of residues 1-110 displays genesis might be an effective approach to the treatment of limited but significant homology (19%) to that of PDGF, this solid tumours (Folkman, 1971) . There is now much evidence suggests that the first 110 residues of VEGF fold independently to support this proposal. Tumours become vascularized by to form a PDGF-like domain that binds to the VEGFR while inducing angiogenesis in nearby blood vessels, causing them the 55 C-terminal residues form the heparin-binding domain. to produce capillaries that grow into and vascularize the VEGF 121 lacks this basic region and does not bind heparin but tumour. At least 20 peptides have been shown to be directly can trigger angiogenesis and vascular permeability (Houck or indirectly angiogenic but there is mounting evidence Kondo et al., 1995) . the primary regulator of tumour angiogenesis is vascular
The carboxy-terminal peptide (residues 111-165) produced endothelial growth factor (VEGF) . VEGF by plasmin cleavage of VEGF 165 has no affinity for soluble was originally described in highly vascularized tumours where KDR or flt-1 receptors (Keyt et al., 1996a) . VEGF 110 binds to its expression is increased by hypoxia (Shweiki et al., 1992) soluble KDR with similar affinity to VEGF 165 and VEGF 121 and was first isolated from bovine pituitary folliculostellate in the absence of heparin (Keyt et al., 1996a) . By contrast, cells as a secreted heparin-binding protein of 46 kDa molecular VEGF 121 and VEGF 110 bind to flt-1 with 10-20-fold decreased weight (Ferrara and Henzel, 1989) . It is a specific mitogen affinity compared with VEGF 165 (Keyt et al., 1996a) . A for endothelial cells and is a potent inducer of vascular VEGF 165 /VEGF 110 heterodimer has an affinity for flt-1 interpermeability, which allows tumour cells to enter blood vessels mediate between VEGF 110 and VEGF 165 homodimers (Keyt (Ferrara and Henzel, 1989; Houck et al., 1991) . The growth et al., 1996a) . These results show that the C-terminal domain of tumours in vivo can be suppressed by monoclonal antibodies of VEGF contains determinants for binding to flt-1 even though raised against VEGF but these antibodies have no effect on the 55 amino acid peptide by itself has no detectable affinity the growth of tumour cells in vitro (Kim et al., 1993) . VEGF for flt-1. is overexpressed in glioblastoma cells and endothelial cells in In addition to VEGF, placenta growth factor (PIGF) has tumours exhibit a 2-3-fold increased expression of the VEGF been shown to bind to flt-1 with high affinity, but not to KDR receptor in vivo (Plate et al., 1992) . Glioblastoma growth in vivo can be inhibited by transfecting endothelial cells with (Kendall et al., 1994) . PIGF induces procoagulant tissue factor production by monocytes and endothelial cells and is a very charged residues involved in receptor binding for the corresponding residues in PDGF. weak stimulator of endothelial cell chemotaxis and proliferation (Clauss et al., 1996) . The sequence of PIGF is 47% identical
In the present work, models of the PDGF-like domains of VEGF and PIGF have been built by homology modelling with that of VEGF. Alternate splicing of mRNA for PIGF generates two variants containing 132 and 153 amino acids using the crystallographic structure of PDGF-BB as a template. Deletions in the loop regions were modelled using database (Maglione et al., 1993) , known as PIGF-1 and PIGF-2, respectively. The insertion of a 21 amino acid basic region searching and a systematic classification of β hairpin structures (Sibanda et al., 1989) . The models were refined using energy near the C-terminus of the longer form confers heparin-binding ability on it (Hauser and Weich, 1993) . minimization and molecular dynamics. The correctness of the models was assessed by evaluating the compatibility of The active forms of VEGF and PIGF are dimeric; in addition to VEGF and PIGF homodimers, a heterodimer of the sequences with the cystine knot fold. This was done by comparing the models with their sequences using a 3D profile VEGF and PIGF has been purified and characterized (DiSalvo et al., 1995) . Heterodimers composed of combinations of computed from the atomic coordinates of the models and calculating the compatibility of each residue in the sequence VEGF 121 , VEGF 165 , PIGF-1 and PIGF-2 have been synthesized in vitro from monomers and shown to have mitogenic with the environment defined by its position in the profile. The sum of the compatibility scores over all residues in the activity (Birkenhäger et al., 1996) . That the various heterodimers are biologically active suggests that the determinants sequence gives the self-compatibility score; it has been shown that the 3D profiles of correct protein structures match their of dimerization are located in the first~110 residues of VEGF and PIGF. Homodimeric PIGF has very weak mitogenic sequences with high self-compatibility scores (Lüthy et al., 1992) . activity compared with homodimeric VEGF and the VEGF/ PIGF heterodimer (DiSalvo et al., 1995) ; this is possibly Given the receptor-binding affinity of VEGF 110 , this model should contain all the determinants of KDR binding and the because the KDR/flk-1 receptor can transduce a mitogenic signal while activation of the flt-1 receptor does not seem to most important determinants of flt-1 binding. The model of VEGF is consistent with the available data on the residues produce a similar response (de Vries et al., 1992; Millauer et al., 1994) .
that mediate receptor binding. No corresponding data for PIGF are available at the time of writing. It is hoped that the models The VEGF and PIGF genes display a limited sequence similarity to that of platelet-derived growth factor (PDGF), a will stimulate and guide further work to identify the residues that determine receptor binding in VEGF and PIGF. The member of the cystine knot growth factor family that also includes transforming growth factor β (TGFβ), nerve growth models suggest an explanation for the difference in receptorbinding specificity of VEGF and PIGF. factor (NGF) and chorionic gonadotropin (CG) (McDonald and Hendrickson, 1993) . The characteristic fold of this family Materials and methods is a pair of twisted antiparallel β sheets linked by a cystine knot formed by three disulphide bonds (Murray-Rust et al.,
The X-ray structure of PDGF-BB at 3.0 Å resolution was used as the basis of the models (Oefner et al., 1992) . Monomer A 1993). One of the disulphide bonds penetrates a ring formed by the other two bonds and the backbone atoms linking them.
of the PDGF structure was used as the template since this contains the more complete set of coordinates. Sequences were The sequence similarity in the family is low but the residues involved in the cystine knot are conserved. The structures are aligned using Clustal (Higgins and Sharp, 1988) and manually adjusted to preserve the β sheet structure ( Figure 13 ). Molecular most similar about the knot and diverge rapidly from each other as the distance from the knot increases. The β strands graphics and model building were done using the InsightII software package (Biosym Technologies, 1994) running on a have similar hydrogen-bonding patterns in each structure. The cystine knot growth factors are dimeric in vivo but the mode Silicon Graphics Indy workstation. Attempts to predict the secondary structure of VEGF and PIGF using the PredictProtein of dimerization is different in each case. The mechanism of action is thought to involve ligand-induced dimerization of the (Rost, 1996) and SOPM algorithms (Geourjon and Deleage, 1995) did not produce useful information. tyrosine kinase receptors.
The cysteines involved in forming the cystine knot are The PDGF(A) structure corresponds to residues 19-109 of VEGF/PIGF. There are no coordinates for the residues in conserved in the sequences of VEGF and PIGF. Two other cysteines that are essential for dimerization of PDGF are also PDGF(A) corresponding to residues 38-44 of VEGF/PIGF. This is due to proteolytic cleavage in this region of PDGF, conserved in VEGF and PIGF. These cysteines have been shown to be essential for the dimerization and biological which makes it impossible to resolve the structure of loop I. The Homology module of the InsightII package was used to activity of VEGF (Pötgens et al., 1994) .
Because of the low sequence similarity among the cystine build coordinates for residues 17-37, 45-83 and 89-109, using PDGF(A) as the basis. Loop II (residues 62-64) is the same knot growth factors, a comparison of the sequences of VEGF and PIGF with those of PDGF-A and PDGF-B gives little length in PDGF and VEGF/PIGF, so this loop was built using the loop from PDGF. Loops I and III were built by database insight into the receptor-binding determinants. Alaninescanning mutagenesis has been used to identify charged searching using the Homology module. Loop III (residues 84-88) is a β hairpin in the growth factors and was modelled residues involved in VEGF binding to flt-1 and KDR (Keyt et al., 1996b) . VEGF binding to KDR/flk-1 is mediated by a using the published systematic classification of β hairpins (Sibanda et al., 1989) as a guide. Each loop was chosen to positively charged surface while binding to flt-1 is due to negatively charged residues. A model of VEGF based on the have a minimum root mean square (r.m.s.) distance between the tails of the loop and the sheets and to have the maximum structure of PDGF shows that these residues are clustered in loops at opposite ends of the VEGF dimer (Keyt et al., 1996b) .
sequence similarity with VEGF/PIGF. In addition, the compatibility of residues in the loop with the environments provided This model was constructed by aligning the sequence of VEGF with that of PDGF and substituting the side chains of the by the fragments was assessed using the Profiles program. The models were not refined before being tested by Profiles since algorithm with the CHARMM forcefield (Brooks et al., 1983) . Initially only hydrogens were minimized, then water molecules, experience has shown that refinement does not substantially improve the profile of a loop that is misfolded in the followed by side chains and then the entire model. The model was then subjected to molecular dynamics. A 1 fs time step unrefined model.
The disulphide bonds in the cystine knot were formed was used throughout the molecular dynamics simulation. The non-bonded cut-off distance was 8 Å and the dielectric was between Cys26-Cys68, Cys57-Cys102 and Cys60-Cys104. A dimeric model was constructed in the same orientation as the distance dependent. The solvated model was heated from 0 to 300 K over 1 ps and then equilibrated for 10 ps. This was PDGF dimer and intersubunit disulphide bonds formed between Cys51 and Cys60. This seemed the most likely orientation followed by free dynamics at 300 K for 25 ps. Bonds involving hydrogen atoms were constrained. The model was then because the Cys residues involved in the intersubunit disulphide bond are conserved in VEGF and PIGF and it has been shown quenched from 300 to 0 K over 1 ps and reminimized without constraints. by site-directed mutagenesis of these Cys residues that a similar pair of disulphide bonds is necessary for the dimerization and Stereochemical analysis of the models was performed using PROCHECK (Laskowski et al., 1993) . The quality of the biological activity of VEGF (Pötgens et al., 1994) .
The bond lengths and angles at the splice points where models was assessed using Profiles (Lüthy et al., 1992) . Electrostatic potential grids were created using DelPhi (Sharp loops were added were refined using the Splice Repair facility of the Homology module. All residues except the two next to and Honig, 1990). All protein charges were taken from the AMBER charge templates provided with the DelPhi program the splice points were fixed, a torsion force was placed on the ω angles of the peptide bonds at the splice point and 100 (Sharp and Honig, 1990 ). steps of steepest descent minimization were performed. The
Results and discussion conformations of mutated side chains were then adjusted using an automated procedure that minimizes the energy of side MOLSCRIPT diagrams of VEGF and PIGF are shown in Figures 1 and 2 . The dimer structure is similar to that in chain conformations by a systematic search of rotamer conformations.
PDGF but is more curved along the long axis (Figures 3 and  4) . The r.m.s differences were calculated between the starting A Profiles (Lüthy et al., 1992) analysis of the unrefined VEGF model showed that residues 17 and 18 were in very and refined structures (Table I) . These indicate that the refined structures have changed somewhat from the initial structure. incompatible environments. These hydrophobic residues may interact with the heparin-binding domain. These hydrophobic
The side chain r.m.s. differences are large since the sequence identity between PDGF and VEGF/PIGF is low and the dimer residues lie on the opposite face of the dimer to the receptorbinding loops and they may interact with the heparin-binding lacks a hydrophobic core in which the conformational flexibility of the side chains would be restricted. A comparison of the domain. Residues 17 and 18 were cut from the model and the dimer was re-refined.
structures of PDGF, TGFβ2 and NGF shows that their backbones diverge rapidly from each other away from the cystine The dimeric model was solvated with a 9 Å shell of TIP3P water (Jorgensen et al., 1983) . Molecular mechanics and knot. It seems reasonable, therefore, that the backbones of the refined VEGF/PIGF models diverge from that of the PDGF dynamics were performed using CHARMM with a united atom forcefield (Brooks et al., 1983 ). The solvated model was template. Ramachandran plots of the backbone angles ( Figures  5 and 6 ) in the models show that they fall into commonly energy minimized using the Adopted Basis Newton-Raphson observed regions of φ-ψ space. The conserved glycine in the hydrophobic residue may change the positions of loops I and II relative to each other since this residue is buried along cystine knot has a positive φ conformation as is observed in PDGF and TGFβ2. The disulphide bonds in the cysteine knot the interface between the loops. The twofold symmetry of the dimer causes the clustering of the loops at the ends of the have similar conformations to those in PDGF. The β bulge preceding Cys97 in PDGF is also present before Cys102 in dimer. In the other cystine knot growth factors the residues involved in receptor binding are located in the loops. If this VEGF and PIGF. The dimer has the shape of a shallow trough with loop I projecting from the concave surface. The structure is the case in PIGF and VEGF, then the loops will form two identical binding regions at opposite ends of the dimer that of loop I was built based on the structure of residues A39-A48 of PDB entry 3rp2. The systematic classification of β could bind two receptor molecules and induce receptor dimerization and activation. Mutations in loop I of PDGF do hairpins (Sibanda et al., 1989) predicts that the deletion of three residues in loop II will change the class 2:2IЈ hairpin in not disrupt the structure of the rest of the protein and this may also be the case in VEGF/PIGF, since this loop points into the loop II of PDGF to a class 3:5 hairpin. Loop II was built using a class 3:5 hairpin from 1sgt ( Figure 7) . The hydrogen bonding solvent and does not interact with the body of the protein.
It has been shown that VEGF is only active in the dimeric pattern in the β sheets is similar to that in PDGF. There are two hydrogen bonds between Lys32 and Met65 (Ser30 and form and that dimerization is dependent on the formation of an intersubunit disulphide bond between Cys51 of one subunit Leu63 in PIGF), causing a bulge in the β strand following loop I. Mutation of Met65 (Leu63 in PIGF) to a nonand Cys60 of the other (Pötgens et al., 1994) . Mutants lacking either of these Cys are unable to form dimers. The coexpression backbone ring of the knot. Cys26 forms one half of the disulphide bond that penetrates the ring of the cystine knot; of Cys51→Ser51 mutants with Cys60→Ser60 mutants leads to formation of heterodimers that are fully active despite mutation of Cys26 may disrupt the tight packing in the knot. One study (Pötgens et al., 1994) found that the mutant having only one intersubunit disulphide bond.
The cysteine knot is formed by the disulphide bonds Cys26-Cys57→Ser57 can still form dimers at the level of 50% of the wild type and that these dimers are biologically active but Cys68, Cys57-Cys102 and Cys61-Cys104. These disulphide bonds have similar conformations to those in PDGF. The another (Claffey et al., 1995) found that, like the other mutants, this mutant is unable even to dimerize. Cys57 is at the end of mutation of any one of Cys26, Cys57, Cys61 or Cys68 to a Ser residue results in impaired dimerization (Pötgens et al., β strand 2 next to loop II and may be less crucial to the integrity of the fold; mutants at this site might still be correctly 1994; Claffey et al., 1995) . This cannot be due to disruption of an intersubunit disulphide bond involving these Cys residues folded and able to form noncovalent dimers. It is interesting that Claffey et al. (1995) found that the mutation Cys102→Ser since they are not in a position to form disulphide bonds with any of the Cys residues in the symmetry-related subunit. These prevents the synthesis and/or secretion of this isoform. In addition, this isoform is a dominant-negative mutant that limits mutations disrupt the structure of the cystine knot, causing a change in the position of Cys60, which is located within the the synthesis and/or secretion of wild-type VEGF. This suggests subunit hydrogen bonding. There are several charge pairs buried along the dimer interface: in VEGF Lys48 forms charge pairs with Asp63 of the other monomer while Arg82 forms a charge pair with Glu64. In PIGF there are charge pairs formed by Lys82 with Glu64 and Glu30 with Arg27. A striking feature of the models is that almost none of the hydrophobic residues have more than 90% of their accessible surface area buried in the interior of the protein. The only exception is Val52, which is completely buried (0% of surface area accessible to solvent) in both VEGF and PIGF. This is adjacent to Cys51 and the burial of this residue may play a part in determining the conformation of the cystine knot. However, dimer formation does bury some hydrophobic surface area, as can be seen from a comparison of the profiles of the monomeric and dimeric forms of VEGF and PIGF (Figures 8 and 9 ). Hydrophobic residues involved in the dimer interface are listed in Table II . The residues at positions 20, 29, 43, 46, 52, 78, 81, 83 and show that the PDGF-like domains of VEGF and PIGF are
Negative S scores indicate putatively misfolded regions. A smoothing window size of 21 residues is used and scores for the first ten and last ten essentially two-dimensional structures that lack a hydroresidues have no significance.
phobic core. The Profiles suite of programs (Lüthy et al., 1992) was used to assess the quality of the models. Profiles measures the that the Cys102→Ser mutant can form a heterodimer with normal VEGF that is subsequently degraded intracellularly.
compatibility of each residue in a model with its environment and calculates a Z score that is a measure of the compatibility The stability of the dimer may also be affected by inter- Fig. 10 . Solvent-accessible surfaces of the VEGF (A) and PIGF (B) monomers coloured according to the electrostatic energy at each point on the surface. The energies were taken from an electrostatic grid calculated using the DelPhi module in InsightII. The units of the spectrum are kT.
of the entire sequence with the fold of the model. Correctly bonds. By contrast, the NGF dimer, which is non-covalent, buries 1166 Å 2 of surface area per monomer. folded proteins have a Z score at least 45% of the maximum theoretically possible score (the S score). The dimeric VEGF
The receptor-binding domains of VEGF 206 have been studied using monoclonal antibodies raised against peptides from the model has a Z score that is 57% of the S score. The residue by residue profile (Figures 8 and 9) does not indicate any sequence of VEGF 206 (Sioussat et al., 1993) . Using the Chou and Fasman (1978) algorithm, peptides were predicted to misfolded regions although the scores for loops I and III are low. The dimeric PIGF model has a Z score that is 70% of contain elements of regular secondary structure. The study identified the N-and C-termini of VEGF 206 as being important the S score. While it is possible that the N-terminal region of the domain that could not be modelled interacts with the part in receptor binding. If the models presented are correct then none of the peptides used would include complete loops and modelled here, the Z scores and the profiles indicate that the fold is basically correct. The areas of greatest error are likely the β strands joined by the loops. Since antibodies to proteins are generally formed against three-dimensional structure rather to be the loops, especially the large loop I. A comparison of the profiles of the dimeric and monomeric models (Figures 8 than sequence, antibodies raised against the peptides used in this study would not recognize the loop regions. None of the and 9) shows that dimer formation improves the scores along the dimeric interface by burying hydrophobic residues. available secondary structure predictors is able to predict accurately the secondary structure of the cystine knot growth Dimerization buries about 900 Å 2 of surface area per monomer. Of this, about 380 Å 2 is buried along the dimer interface; this factors and are therefore not useful guides to designing peptides for a study of this kind. is less than in PDGF. Unlike PDGF, VEGF is unable to form stable, biologically active noncovalent dimers. This may be DelPhi calculations of the electrostatic potential over the surface of the dimers reveal a number of differences in the because the smaller surface area buried in VEGF is insufficient to stabilize the dimer in the absence of intersubunit disulphide distribution of positive and negative charges (Figure 10 ). Loop than that in VEGF. This loop also includes a negatively charged side chain, Asp87; the corresponding residue in VEGF is Gln. In both VEGF and PIGF, loop II has a negatively charged patch formed by Asp63, Glu64 and Glu67 in VEGF and by Asp63 and Glu64 in PIGF.
There are several patches of exposed hydrophobic residues on the surfaces of VEGF and PIGF. The residues Met81, Ile83 and Ile91 form a hydrophobic patch on the surface of loop III in VEGF. In PIGF the residue corresponding to Met81 (Leu81) is buried and Ile91 is replaced by a Tyr residue, resulting in a much smaller hydrophobic patch formed by Ile83. The conserved Leu66 is exposed in both VEGF and PIGF. There is a large area of hydrophobic surface formed at the interface of loops I and II by Val33, Val35, Phe37, Leu80 and Val92 in PIGF and by Val33, Ile35, Phe37 and Ile80 in VEGF.
The charged residues in VEGF that are involved in receptor binding have been identified by alanine-scanning mutagenesis. Arg82, Lys84 and His86 in VEGF are critical for binding to KDR/flk-1 while Asp63, Glu64 and Glu67 were implicated in binding to flt-1 and to a lesser extent, KDR (Keyt et al., 1996) . A model of VEGF was constructed by aligning the sequences of VEGF and PDGF and substituting the side chains of these charged residues for the corresponding residues in PDGF. This This model locates the positively charged residues Arg82, Lys84 and His86 in a cluster on the edge of the loop III β hairpin. The model presented here shows that the side chains of Arg82, Lys84, His86 and His90 form a positively charged surface on the plane of the β hairpin, with His86 forming part of the β hairpin (Figures 10 and 11) . Although His90 forms part of this positively charged surface mutation of this residue to Ala has little effect on binding. The position of the negatively charged residues Asp63, Glu64 and Glu67 is similar in both models. The potential extra glycosylation site introduced by mutation of Glu64 is located at the tip of loop II, which mediates binding to flt-1. Glu64 is one of the residues implicated in binding to flt-1; it is therefore not surprising that mutation of this residue to Asn reduces binding to flt-1~40-fold. No effect on binding to either flt-1 or KDR was detected by mutagenesis of charged residues in loop I. The comparison of the models of VEGF and PIGF suggests that the inability of PIGF to bind KDR may be due to differences in the positively charged surface in loop III of PIGF as compared with VEGF and the absence of exposed hydrophobic residues in loops I and II. VEGF has a putative N-linked glycosylation site with the consensus sequence Asn-Thr-Leu, at residues 75-77. Mutation I in VEGF contains a large, elongated negatively charged region formed by Asp34, Gln37, Glu38, Pro40, Asp41, Glu42 of Asn75 to Tyr alters the electrophoretic mobility of the VEGF dimer, consistent with a lack of glycosylation (Claffey and Glu44, whereas this loop in PIGF is almost uncharged. The body of the PIGF dimer contains a large area of positive et al., 1995) . The VEGF model shows that the side chain of Asn75 is exposed to solvent and is located near the middle of charge consisting of Arg55, His99, Arg31, His67, Pro70 and Ser97, which is absent in VEGF. The residues Lys84, His86 the fourth β strand (Figure 11 ). Mutation of this site has no effect on receptor-binding activity (Claffey et al., 1995) , which and His90 in VEGF form an elongated positively charged patch at the tip of loop III. The corresponding hairpin in PIGF is not surprising given that it is not located near the receptorbinding loops. The site is conserved in PIGF. has a positively charged surface formed by the side chains of Arg84 and Arg88 ( Figures 10 and 12) ; this surface is smaller It is hoped that the models presented here will be useful The alignment begins at residue 19 of the mature VEGF sequence and ends at residue 109 of that sequence. This is the region of VEGF corresponding to the model. Cysteine residues involved in the cystine knot are in bold type. Conserved residues are marked by an asterisk and conservative substitutions by a period (.). Residues underlined are in the β sheets.
be used to investigate the determinants of receptor binding. 
